D.A. Davidson & Co’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-107,432
| Closed | -$568K | – | 1480 |
|
|
2025
Q1 | $568K | Buy |
107,432
+91,440
| +572% | +$484K | ﹤0.01% | 965 |
|
|
2024
Q4 | $108K | Sell |
15,992
-98,047
| -86% | -$663K | ﹤0.01% | 1375 |
|
|
2024
Q3 | $752K | Buy |
114,039
+6,505
| +6% | +$42.9K | 0.01% | 869 |
|
|
2024
Q2 | $807K | Buy |
107,534
+96,895
| +911% | +$727K | 0.01% | 805 |
|
|
2024
Q1 | $106K | Buy |
+10,639
| New | +$106K | ﹤0.01% | 1342 |
|